📚 Wiki Antimicrobial & Immune Clavanin

Clavanin

● Preclinical
Clavanin A
Also known as: CLV-A, Tunicate AMP
Page last reviewed

Quick Summary

Clavanin is a histidine-rich alpha-helical antimicrobial peptide originally isolated from the tunicate Styela clava. It is active at low pH, suggesting a role in intracellular killing of phagocytosed bacteria.

Antimicrobial Peptide Preclinical
Clavanin is a histidine-rich alpha-helical antimicrobial peptide originally isolated from the tunicate Styela clava. It is active at low pH, suggesting a role in intracellular killing of phagocytosed bacteria. Clavanin A has attracted attention for its potent activity against antibiotic-resistant organisms.
Storage Stability
Lyophilized
1–2 years (-20°C)
Reconstituted
~30 days (2–8°C)
Room temp
Avoid

Mechanism of Action

pH-Activated Membrane Disruption

Clavanin is a 23-residue alpha-helical peptide with a high histidine content. At acidic pH (such as phagolysosomes), histidine residues become protonated, enhancing membrane binding and disruption. This pH-dependent activation is thought to concentrate its activity at sites of infection.

Inhibition of Macromolecule Synthesis

Clavanin inhibits bacterial respiration and macromolecular synthesis at sub-lethal membrane-disrupting concentrations. It interferes with proton motive force and may target intracellular metabolic processes, contributing to bactericidal activity.


Research Summary

Antibiotic-Resistant Pathogens

Preclinical

Clavanin A demonstrates potent activity against MRSA, VRE, and multidrug-resistant gram-negative bacteria. MIC values of 1-4 mcg/mL have been reported against resistant clinical isolates, supporting its potential as a therapeutic agent for drug-resistant infections.

Biofilm Activity

Preclinical

Clavanin disrupts preformed biofilms and prevents biofilm formation in catheter-related infection models. The peptide retains activity within biofilm matrices, an advantage over conventional antibiotics that poorly penetrate these structures.


Calculate your Clavanin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →

Research Protocols

GoalDoseFrequencyRoute
MIC against MRSA1-4 mcg/mLSingleBroth microdilution
Biofilm prevention8-16 mcg/mLSingleCatheter coating

No established human protocols. Research use only.


Interactions

Synergy
Vancomycin
Synergistic killing of VRE in combination studies
Neutral
Beta-lactams
Complementary mechanisms; no antagonism reported

Safety Profile

Clavanin A shows selectivity for bacterial over mammalian membranes at effective concentrations. Hemolysis occurs at higher doses. The pH-dependent mechanism may improve in vivo selectivity. No clinical safety data available.


References

  • [1]Lee IH et al. (1997). Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes. FEBS Letters, 400(2), 158-162.
  • [2]van Kan EJ et al. (2002). Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry, 41(24), 7529-7539.
Ready to dose Clavanin?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
Verified Scientific Data Last audited:
Data Sources & External References
Source: peer-reviewed literature  ·  Domain: ascendpeptide.org

Suggest a Change

Clavanin · wiki page